BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 415925)

  • 1. Insulin therapy in relation to circulating C-peptide levels.
    Beischer W; Kerner W; Raptis S; Keller L; Beischer B; Pfeiffer EF
    Diabetes; 1978; 27 Suppl 1():235-40. PubMed ID: 415925
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quantitative determination of C-peptide and insulin secretion for the evaluation of therapeutic action in manifest diabetes mellitus].
    Wölk I; Zilker T; Schweigart U; Ermler R; Paterek K; Bottermann P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1388-91. PubMed ID: 417495
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin, C-peptide, and proinsulin in nondiabetics and insulin-treated diabetics. Characterization of the proinsulin in insulin-treated diabetics.
    Heding LG
    Diabetes; 1978; 27 Suppl 1():178-83. PubMed ID: 631439
    [No Abstract]   [Full Text] [Related]  

  • 4. C-peptide measurement and its clinical usefulness: a review.
    Bonser AM; Garcia-Webb P
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):200-6. PubMed ID: 7025733
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood CPR levels in diabetes mellitus during insulin therapy, with special reference to the characteristics of PLC (proinsulin-like components) and C-peptide in fractional analysis].
    Oyama H; Nakajima Y; Amagu A; Matsumura S; Nishida S
    Horumon To Rinsho; 1977 Oct; 25(10):1107-12. PubMed ID: 589809
    [No Abstract]   [Full Text] [Related]  

  • 6. Endogenous insulin secretion measured by C-peptide in maturity-onset diabetes controllable by diet alone.
    Rendell M; Ross DA; Drew HM; Zarriello J
    Arch Intern Med; 1981 Nov; 141(12):1617-22. PubMed ID: 7030247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery from decompensated non-insulin-dependent diabetes mellitus: studies of C-peptide secretion.
    Rendell M; Zarriello J; Drew HM; Dranbauer B; Wilson G; Waud J; Ross D
    Diabetes Care; 1981; 4(3):354-9. PubMed ID: 7047111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta cell function in insulin-treated diabetes mellitus determined by C-peptide measurement].
    Faber OK
    Ugeskr Laeger; 1980 Jan; 142(4):215-21. PubMed ID: 6986696
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plasma C-peptide concentration in normal and different types of diabetic subjects (author's transl)].
    Lu ZL
    Zhonghua Nei Ke Za Zhi; 1981 Aug; 20(8):471-4. PubMed ID: 7039990
    [No Abstract]   [Full Text] [Related]  

  • 10. Basal C-peptide in the discrimination of type I from type II diabetes.
    Webb PG; Bonser AM
    Diabetes Care; 1981; 4(6):616-9. PubMed ID: 6751738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [C-peptide from proinsulin e--theory and practice].
    Malmquist J; Lindgärde F; Almér LO; Johansson E
    Lakartidningen; 1982 Jul; 79(30-31):2716-9. PubMed ID: 6755106
    [No Abstract]   [Full Text] [Related]  

  • 12. [C-peptide and insulin in diabetics].
    Zhonghua Yi Xue Za Zhi; 1982 Nov; 62(11):651-6. PubMed ID: 6819875
    [No Abstract]   [Full Text] [Related]  

  • 13. [C-peptide determination as a parameter for oral diabetes therapy].
    Beischer W; Raptis S; Keller L; Kerner W; Pfeiffer EF
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():791-4. PubMed ID: 829388
    [No Abstract]   [Full Text] [Related]  

  • 14. Home blood glucose levels, glycosylated haemoglobin and serum C-peptide levels in diabetics receiving different insulin regimens.
    Paisey RB; Bradshaw P; Burke BJ; Macfarlane DG; Hartog M
    J R Coll Physicians Lond; 1982 Apr; 16(2):108-12. PubMed ID: 7042962
    [No Abstract]   [Full Text] [Related]  

  • 15. [The clinical value of C-peptide assay (author's transl)].
    Vialettes B; Vague P
    Diabete Metab; 1980 Sep; 6(3):225-9. PubMed ID: 7002655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in CPR and blood metabolites during glucose loading in healthy subjects and patients with various diseases].
    Sakamoto N; Hotta G
    Horumon To Rinsho; 1977 Oct; 25(10):1081-9. PubMed ID: 589807
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in serum C-peptide in glucose tolerance test; with special reference to diabetes and insulinoma].
    Iwaya S; Odagiri R; Tasaka J; Hirata U
    Horumon To Rinsho; 1976; 24(5):443-8. PubMed ID: 187365
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating C-peptide immunoreactivity. Studies in normals and diabetic patients.
    Block MB; Mako ME; Steiner DF; Rubenstein AH
    Diabetes; 1972 Oct; 21(10):1013-26. PubMed ID: 4116300
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dynamics of the glucagon and C-peptide content in Itsenko-Cushing disease].
    Arapova SD; Zavadskiĭ PS; Marova EI
    Sov Med; 1980; (2):42-7. PubMed ID: 6987746
    [No Abstract]   [Full Text] [Related]  

  • 20. C-peptide response to arginine infusion in insulin requiring diabetics.
    Fujii S; Tanaka S; Akai T; Ueda N; Nakatani K; Seki J; Wada M
    Osaka City Med J; 1978; 24(1):25-32. PubMed ID: 377185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.